Company Name: Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of therapies for kidney disease using hypoxia-inducible factor (HIF) biology.

Ticker Symbol: AKBA (NASDAQ)

Company Website: http://akebia.com

Social Media:

Akebia Therapeutics LinkedIn

Akebia Therapeutics Twitter

Headquarters: Cambridge, MA